This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)
C3_CONNECTIVE_SOFT_NAS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
1526 |
4. Check minimum number of eventsNone |
1526 |
5. Include endpointsNone |
1526 |
6. Filter based on genotype QC (FinnGen only) |
1526 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1526 | 731 | 795 |
| Unadjusted period prevalence (%) | 0.30 | 0.25 | 0.35 |
| Median age at first event (years) | 61.97 | 60.03 | 63.75 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 735
- Matched controls
- 7348
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
248.4
224
*
JN4BD
NOMESCO Finland
Extensive body CT
22.7
162.7
246
159
H02AB02
ATC
dexamethasone; systemic
68.3
144.7
165
31
A03FA01
ATC
metoclopramide; systemic, rectal
10.0
128.2
294
459
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
124.6
116
*
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
119.0
111
*
A04AA02
ATC
granisetron; systemic, transdermal
236.0
118.4
119
6
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1289.0
115.9
110
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
113.5
106
*
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
110.2
103
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
106.9
100
*
L03AA02
ATC
filgrastim; parenteral
1166.5
106.0
101
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
47.0
97.5
119
30
L03AA13
ATC
pegfilgrastim; parenteral
+∞
94.9
89
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
32.5
92.7
123
45
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
85.1
80
*
WF002
NOMESCO Finland
Radical radiotherapy
316.3
84.5
84
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
893.8
83.2
80
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
303.1
81.3
81
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
856.3
79.9
77
*
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
29.2
79.2
108
43
A04AA01
ATC
ondansetron; systemic, rectal
22.3
75.1
111
58
XX3DW
NOMESCO Finland
Time consuming IT work
11.8
73.8
143
147
JN4AD
NOMESCO Finland
Body CT examination
14.8
72.2
125
100
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.1
69.8
469
2223
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
11.0
65.9
132
143
C49.22
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including hip liposarcoma
+∞
65.6
62
*
C49.2
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of lower limb, including hip
+∞
64.5
61
*
Z51.5
ICD-10 Finland
Palliative care
18.2
63.1
100
63
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
229.2
62.1
63
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
649.7
61.7
60
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
61.3
58
*
N02AA05
ATC
oxycodone; systemic
5.5
60.5
205
483
A04AD12
ATC
aprepitant; systemic
+∞
58.1
55
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
58.1
55
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
579.2
55.3
54
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.8
54.9
304
1144
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
54.9
52
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
53.8
51
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
51.7
49
*
8850/3-C49.2
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
51.7
49
*
B01AB05
ATC
enoxaparin; parenteral
3.6
51.1
307
1220
WW500
NOMESCO Finland
Blood transfusion
17.7
50.9
81
51
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
49.5
47
*
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
133.8
47.4
50
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
8.8
47.2
106
138
C61
ICD-10 Finland
Malignant neoplasm of prostate
250.5
46.5
47
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
45.3
43
*
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
62.0
45.0
52
9
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
20.9
44.9
67
35
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
44.6
269
1047
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
125.3
44.3
47
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
44.2
42
*
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
43.1
41
*
R4110
NOMESCO Finland
Physiotherapy
3.3
42.7
273
1103
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
14.1
42.5
74
58
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
16.9
42.2
68
44
ZZA00
NOMESCO Finland
Split skin graft
11.5
40.3
77
74
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
7.4
40.2
100
152
JN4CD
NOMESCO Finland
Very extensive body CT
19.4
40.0
61
34
C49.23
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip leiomyosarcoma
+∞
38.9
37
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
37.8
36
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
385.8
37.3
37
*
WF004
NOMESCO Finland
Palliative radiotherapy
385.8
37.3
37
*
8800/3-C49.2
ICD-O-3
Sarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
36.8
35
*
C49.19
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder other or unspecified tumor
+∞
36.8
35
*
B01AB10
ATC
tinzaparin; parenteral
7.6
36.7
90
133
XW000
NOMESCO Finland
Bone marrow biopsy
10.5
36.6
73
76
D70.82
ICD-10 Finland
Drug-induced neutropenia
63.5
36.5
42
7
TPX10
NOMESCO Finland
Implantation of vascular injection port
14.6
36.4
62
46
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
374.7
36.3
36
*
159
Kela drug reimbursment
Pazopanib
+∞
35.7
34
*
C49.10
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder without histology
+∞
34.6
33
*
WZC30
NOMESCO Finland
Teaching
4.5
34.2
134
350
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
33.6
32
*
8890/3-C49.2
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
33.6
32
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
33.6
32
*
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
19.8
33.1
50
27
ZZR00
NOMESCO Finland
Flap of skin
25.7
33.1
46
19
115
Kela drug reimbursment
Breast cancer
+∞
32.5
31
*
C49.49
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor
+∞
32.5
31
*
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
11.0
32.5
63
62
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
118.6
31.9
34
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
31.5
30
*
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
44.3
31.2
38
9
R4120
NOMESCO Finland
Occupational therapy
5.0
31.0
106
239
WX302
NOMESCO Finland
Thoracal epidural anesthesy
9.6
30.8
64
72
C49.39
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax other or unspecified tumor
+∞
30.4
29
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
30.4
29
*
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
10.3
30.0
60
63
WX402
NOMESCO Finland
General anaesthesia
3.6
29.5
149
484
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
21.7
29.5
43
21
L01XE11
ATC
[U] pazopanib; oral
+∞
29.4
28
*
A79
ICPC
Malignancy NOS
+∞
29.4
28
*
ZZR10
NOMESCO Finland
Flap of skin and muscle
68.9
29.1
33
5
JN6AD
NOMESCO Finland
CT of torso and neck
156.1
28.9
30
*
C49.21
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip malignant fibrotic histiocytoma
+∞
28.3
27
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.9
27.5
122
354
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
27.2
26
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
27.2
26
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
26.2
25
*
NGR30
NOMESCO Finland
Extensive or radikal excision of tumor of knee or lower leg
+∞
26.2
25
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.0
26.0
74
134
D17.2
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
10.6
25.6
50
50
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
13.7
25.5
44
34
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.8
25.2
88
202
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
25.1
24
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
25.1
24
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
25.1
24
*
N03AX16
ATC
pregabalin; oral
2.6
24.9
217
1008
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
134.5
24.7
26
*
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
11.3
24.4
46
43
8850/3-C49.6
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
24.1
23
*
C49.30
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax without histology
+∞
24.1
23
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
24.1
23
*
C49.12
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder liposarcoma
+∞
24.1
23
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
8.1
24.0
55
73
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
89.7
23.8
26
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.1
23.8
78
167
ZX120
NOMESCO Finland
Intravenous
4.4
23.5
91
231
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
16.9
23.4
37
23
C49.99
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue other or unspecified tumor
+∞
23.0
22
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
23.0
22
*
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
7.7
22.9
54
75
343
Kela drug reimbursment
Pazopanib
+∞
22.0
21
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
22.0
21
*
C48.02
ICD-10 Finland
Malignant tumor of the retroperitoneal space liposarcoma
+∞
22.0
21
*
C49.11
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder malignant fibrotic histiocytoma
+∞
22.0
21
*
C49.90
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue without histology
+∞
22.0
21
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
22.0
21
*
116
Kela drug reimbursment
Prostate cancer
+∞
22.0
21
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
5.4
21.5
66
131
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.8
21.5
162
682
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
8.4
21.3
47
59
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
4.5
21.2
78
188
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
25.1
21.0
29
12
C49.4
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of abdomen
+∞
20.9
20
*
NB1DG
NOMESCO Finland
Shoulder and humerus very extensive MRI examination with high intensity magnet
23.1
20.5
29
13
WX306
NOMESCO Finland
Lumbar epidural anesthesy
5.2
20.4
65
135
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
19.9
19
*
C49.28
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip Ewing's sarcoma
+∞
19.9
19
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
19.9
19
*
9680/3-C49.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of head, face, and neck
+∞
19.9
19
*
8850/3-C49.1
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
19.9
19
*
GD1AD
NOMESCO Finland
Thorax CT examination
5.9
19.7
56
101
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
107.9
19.7
21
*
S18
ICPC
Laceration/cut
2.1
19.6
324
2003
R50.9
ICD-10 Finland
Fever, unspecified
2.9
19.2
128
496
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
18.8
18
*
C49.25
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip fibrosarcoma
+∞
18.8
18
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
18.8
18
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
18.8
18
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
18.8
18
*
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
71.8
18.8
21
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.3
18.6
102
344
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.5
17.9
39
48
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
17.8
17
*
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
21.5
17.4
25
12
ZX112
NOMESCO Finland
Subcutaneous
16.4
17.1
27
17
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
51.3
17.1
20
*
N02BE01
ATC
paracetamol; systemic, rectal
2.3
16.9
625
5215
8890/3-C49.1
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
16.7
16
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
+∞
16.7
16
*
C49.1
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of upper limb, including shoulder
+∞
16.7
16
*
C49.3
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of thorax
+∞
16.7
16
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
16.7
16
*
C49.59
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis other or unspecified tumor
+∞
16.7
16
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
6.7
16.5
42
66
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
41.1
16.4
20
5
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
16.1
175
881
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
48.6
16.1
19
*
L02BG04
ATC
letrozole; oral
14.9
15.9
26
18
R22.3
ICD-10 Finland
Localized swelling, mass and lump, upper limb
7.8
15.8
36
48
JAH00
NOMESCO Finland
Laparotomy
6.6
15.7
40
63
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
17.7
15.7
24
14
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
15.7
15
*
L01BC06
ATC
capecitabine; oral
+∞
15.7
15
*
8802/3-C49.2
ICD-O-3
Giant cell sarcoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
15.7
15
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
15.7
15
*
YX9VG
NOMESCO Finland
Other MRI eamination with high intensity magnet for dose design of radiotherapy
+∞
15.7
15
*
C49.00
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck without histology
+∞
15.7
15
*
C49.9
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue, unspecified
+∞
15.7
15
*
R4190
NOMESCO Finland
Nutritional therapy
7.7
15.6
36
49
GA1CG
NOMESCO Finland
Extensive MRI of chest
46.0
15.1
18
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
10.4
15.1
29
29
GAE06
NOMESCO Finland
Excision of lesion of chest wall
57.9
14.8
17
*
1XC02
NOMESCO Finland
NA
21.6
14.7
21
10
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
14.6
14
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
14.6
14
*
8800/3-C49.1
ICD-O-3
Sarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
14.6
14
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
14.6
14
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
14.6
14
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
14.6
14
*
189
Kela drug reimbursment
Imatinib
+∞
14.6
14
*
C49.09
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck other or unspecified tumor
+∞
14.6
14
*
L71
ICPC
Malignant neoplasm musculoskeletal
+∞
14.6
14
*
ZXA00
NOMESCO Finland
Right side
2.0
14.6
219
1266
NJ3DG
NOMESCO Finland
Very extensive MRI examination of extremities with high intensity magnet
81.7
14.6
16
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
152.8
14.5
15
*
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
36.8
14.5
18
5
NG1DG
NOMESCO Finland
Knee and lower leg very extensive MRI examination with high intensity magnet
27.8
14.3
19
7
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
5.6
14.3
41
76
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.8
14.2
47
102
NAR20
NOMESCO Finland
Complete excision of soft tissue tumour of spine, unspecified
43.4
14.1
17
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
54.4
13.9
16
*
L02AE02
ATC
leuprorelin; implant, parenteral
24.3
13.8
19
8
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
13.7
141
688
A02BC02
ATC
pantoprazole; systemic
1.8
13.6
465
3569
C49.15
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder fibrosarcoma
+∞
13.6
13
*
8830/3-C49.2
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
13.6
13
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
13.6
13
*
C49.13
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder leiomyosarcoma
+∞
13.6
13
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
13.6
13
*
C49.42
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen liposarcoma
+∞
13.6
13
*
GA1BG
NOMESCO Finland
MRI of chest
+∞
13.6
13
*
C49.32
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax liposarcoma
+∞
13.6
13
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
13.6
13
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
13.6
13
*
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
5.2
13.6
42
85
NBR20
NOMESCO Finland
Intralesional or marginal excision of soft tissue tumour of shoulder or upper arm
26.3
13.4
18
7
J01MA12
ATC
levofloxacin; systemic
2.2
13.2
149
760
A06AH03
ATC
naloxegol; oral
40.8
13.2
16
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
40.8
13.2
16
*
B01AB04
ATC
dalteparin; parenteral
4.4
13.1
48
116
Z31.5
ICD-10 Finland
Genetic counselling
5.5
13.0
38
72
TQW11
NOMESCO Finland
Vacuum treatment of wound
6.1
13.0
35
60
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
23.0
12.9
18
8
PJA10
NOMESCO Finland
Exploration of lymph nodes
50.9
12.9
15
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.7
12.6
91
366
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
71.1
12.6
14
*
9040/3-C49.2
ICD-O-3
Synovial sarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
12.5
12
*
9680/3-C49.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
12.5
12
*
8890/3-C49.4
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
12.5
12
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
12.5
12
*
L01XE01
ATC
[U] imatinib; oral
+∞
12.5
12
*
C48.09
ICD-10 Finland
Malignant tumor of the retroperitoneal space other or unspecified tumor
+∞
12.5
12
*
C49.5
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of pelvis
+∞
12.5
12
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
24.8
12.5
17
7
ZXA05
NOMESCO Finland
Left side
1.9
12.3
208
1246
HA1AA
NOMESCO Finland
X-ray mammography
5.5
12.1
35
66
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.7
12.1
34
62
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
16.7
11.7
18
11
L02BA01
ATC
tamoxifen; oral
30.6
11.7
15
5
NGR20
NOMESCO Finland
Intralesional or marginal excision of tumor of knee or lower leg
66.0
11.6
13
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
19.3
11.6
17
9
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
23.3
11.6
16
7
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
11.3
11.6
21
19
C49.52
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis liposarcoma
+∞
11.5
11
*
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
+∞
11.5
11
*
17131
ICD-8 Finland
Malignant neoplasm of connective and other soft tissue, Lower limb (including hip)
+∞
11.5
11
*
C49
ICD-10 Finland
Malignant neoplasm of other connective and soft tissue
+∞
11.5
11
*
8850/3-C49.4
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
11.5
11
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
11.5
11
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
11.5
11
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
11.5
11
*
8811/3-C49.2
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
11.5
11
*
C48.03
ICD-10 Finland
Malignant tumor of the retroperitoneal space leiomyosarcoma
+∞
11.5
11
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
11.5
11
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
11.5
11
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
11.5
11
*
C49.0
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of head, face and neck
+∞
11.5
11
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
11.5
11
*
TPX15
NOMESCO Finland
Removal of vascular injection port
+∞
11.5
11
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
11.5
11
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
121.8
11.5
12
*
JAA10
NOMESCO Finland
Excision of lesion of abdominal wall
121.8
11.5
12
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
35.6
11.3
14
*
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
20.4
11.2
16
8
ZZR30
NOMESCO Finland
Flap of muscle
15.8
10.9
17
11
NK6AN
NOMESCO Finland
Total body bone isotope imaging
18.1
10.8
16
9
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.5
10.7
87
376
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
60.9
10.6
12
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
7.1
10.6
25
36
WX110
NOMESCO Finland
Local anesthesy
1.7
10.5
449
3546
Z42.4
ICD-10 Finland
Follow-up care involving plastic surgery of lower extremity
111.5
10.4
11
*
8830/3-C49.1
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
10.4
10
*
8852/3-C49.2
ICD-O-3
Myxoid liposarcoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
10.4
10
*
YN1CD
NOMESCO Finland
Very extensive CT examination of extremities for dose design of radiotherapy
+∞
10.4
10
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
10.4
10
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
10.4
10
*
8830/3-C49.6
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
10.4
10
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
10.4
10
*
9680/3-C49.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues, NOS
+∞
10.4
10
*
C49.60
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue at the torso, unspecified location without histology
+∞
10.4
10
*
C49.43
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen leiomyosarcoma
+∞
10.4
10
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
10.4
10
*
L01CB01
ATC
etoposide; systemic
+∞
10.4
10
*
C49.02
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck liposarcoma
+∞
10.4
10
*
GAE23
NOMESCO Finland
Resection of chest wall and prosthetic repair
+∞
10.4
10
*
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
+∞
10.4
10
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
10.4
10
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.8
10.4
68
259
HAB40
NOMESCO Finland
Wedge excision of mammary gland
12.3
10.4
18
15
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
16.3
10.4
16
10
SPAT1153
SPAT
Removal of sutures
1.8
10.3
228
1479
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
9.8
10.3
20
21
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.9
10.0
61
222
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
55.7
9.7
11
*
TNG34
NOMESCO Finland
Major custom moulded orthopaedic cast, knee or lower leg
6.9
9.7
23
34
M04AA01
ATC
allopurinol; systemic
2.1
9.6
114
587
N02AX02
ATC
tramadol; systemic, rectal
1.7
9.6
302
2171
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
9.3
9.6
19
21
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
9.5
96
459
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.2
9.5
50
166
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
101.2
9.4
10
*
C49.98
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue Ewing's sarcoma
+∞
9.4
9
*
L02BB03
ATC
bicalutamide; oral
+∞
9.4
9
*
C49.04
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck rhabdomyosarcoma
+∞
9.4
9
*
C49.31
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax malignant fibrotic histiocytoma
+∞
9.4
9
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
9.4
9
*
C49.53
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis leiomyosarcoma
+∞
9.4
9
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
9.4
9
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
9.4
9
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
9.4
9
*
8810/3-C49.1
ICD-O-3
Fibrosarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
9.4
9
*
C49.50
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis without histology
+∞
9.4
9
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
37.2
9.0
11
*
NF3AA
NOMESCO Finland
Femur X-ray examination
5.1
9.0
27
54
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.5
8.8
30
69
GD1CG
NOMESCO Finland
Extensive examination of lungs and pleura with high intensity magnet
50.6
8.7
10
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.3
8.7
31
75
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
6.3
8.7
22
36
TQW99
NOMESCO Finland
Other minor procedure on skin
3.7
8.6
36
101
JAG60
NOMESCO Finland
Reconstruction of abdominal wall using prosthetic material
27.9
8.5
11
*
WF099
NOMESCO Finland
Other radiotherapy
91.0
8.4
9
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
91.0
8.4
9
*
8810/3-C49.2
ICD-O-3
Fibrosarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
8.3
8
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
8.3
8
*
8811/3-C49.1
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
8.3
8
*
L04AX04
ATC
lenalidomide; oral
+∞
8.3
8
*
NCR30
NOMESCO Finland
Extended excision of soft tissue tumour of elbow or forearm
+∞
8.3
8
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
8.3
8
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
8.3
8
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
+∞
8.3
8
*
C49.69
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the torso, unspecified localization other or unspecified tumor
+∞
8.3
8
*
C48.0
ICD-10 Finland
Malignant neoplasm: Retroperitoneum
+∞
8.3
8
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
8.3
8
*
9680/3-C49.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of thorax
+∞
8.3
8
*
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
8.3
8
*
153
Kela drug reimbursment
Lenalidomid
+∞
8.3
8
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
8.3
8
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
8.3
8
*
WW409
NOMESCO Finland
Other aferesis
+∞
8.3
8
*
C49.18
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder Ewing's sarcoma
+∞
8.3
8
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
8.3
8
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.5
8.3
38
114
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.6
8.2
60
247
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
4.6
8.1
27
61
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
33.7
8.1
10
*
S77
ICPC
Malignant neoplasm of skin
33.7
8.1
10
*
TKE00
NOMESCO Finland
Needle biopsy of prostate
4.2
8.1
29
71
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
10.2
8.1
15
15
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
22.3
8.0
11
5
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
22.3
8.0
11
5
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
6.7
7.9
19
29
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
4.5
7.8
26
59
D17.9
ICD-10 Finland
Benign lipomatous neoplasm, unspecified
6.5
7.7
19
30
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
6.0
7.7
20
34
NE1CM
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with 3 Tesla magnet
18.6
7.6
11
6
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
80.8
7.4
8
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
80.8
7.4
8
*
N05BA06
ATC
lorazepam; systemic, sublingual
2.8
7.4
45
166
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.5
7.4
57
240
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
7.4
60
260
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.8
7.4
47
178
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.4
7.3
60
261
C40.29
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity other or unspecified histology
+∞
7.3
7
*
NHR30
NOMESCO Finland
Complete excision of soft tissue tumour of ankle or foot
+∞
7.3
7
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
7.3
7
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
7.3
7
*
8800/3-C49.6
ICD-O-3
Sarcoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
7.3
7
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
7.3
7
*
8800/3-C49.9
ICD-O-3
Sarcoma, NOS, of connective, Subcutaneous and other soft tissues, NOS
+∞
7.3
7
*
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
7.3
7
*
C49.03
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck Leiomyosarcoma
+∞
7.3
7
*
9680/3-C49.6
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
7.3
7
*
YJ1CD
NOMESCO Finland
Very extensive CT examination of abdomen for dose design of radiotherapy
+∞
7.3
7
*
1713K
ICD-9 Finland
Malignant neoplasm of connective and other soft tissue, Lower limb, including hip[ALARAAJAN PEHMYTKUDOSSYÖPÄ,MUU HISTOL]
+∞
7.3
7
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
7.3
7
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
NER30
NOMESCO Finland
Extended excision of soft tissue tumour of pelvis
+∞
7.3
7
*
3AA13
NOMESCO Finland
NA
+∞
7.3
7
*
NAR40
NOMESCO Finland
Block excision of soft tissue tumour of spine, unspecified
+∞
7.3
7
*
8811/3-C49.5
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of pelvis
+∞
7.3
7
*
C49.24
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip rhabdomyosarcoma
+∞
7.3
7
*
9680/3-C49.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
7.3
7
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
7.3
7
*
8851/3-C49.2
ICD-O-3
Liposarcoma, well differentiated, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
7.3
7
*
GAE20
NOMESCO Finland
Resection of chest wall and repair using flap
+∞
7.3
7
*
C49.89
ICD-10 Finland
Overall malignant tumor of connective tissue and other soft tissue other or unspecified tumor
+∞
7.3
7
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
7.3
7
*
9680/3-C49.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
7.3
7
*
ZZF00
NOMESCO Finland
Graft of adipose tissue
15.9
7.2
11
7
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
30.3
7.2
9
*
QC9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in upper extremities, unspecified
20.2
7.1
10
5
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
4.1
7.1
26
65
A41.9
ICD-10 Finland
Sepsis, unspecified
3.3
7.1
34
107
WX320
NOMESCO Finland
Spinalanesthesy
1.7
7.1
167
1091
N02AA01
ATC
morphine; systemic, rectal
7.6
6.9
15
20
KAC00
NOMESCO Finland
Nephrectomy
40.4
6.8
8
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
40.4
6.8
8
*
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
40.4
6.8
8
*
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
40.4
6.8
8
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
40.4
6.8
8
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
6.8
111
645
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
16.9
6.8
10
6
J94.8
ICD-10 Finland
Other specified pleural conditions
7.3
6.7
15
21
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.2
6.7
66
315
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
22.7
6.7
9
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
22.7
6.7
9
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
5.2
6.7
19
37
TQW40
NOMESCO Finland
Remowal of suture of skin
2.5
6.7
48
197
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
6.5
6.7
16
25
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
6.6
205
1435
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
4.7
6.4
20
43
NC1DG
NOMESCO Finland
Elbow and forearm very extensive MRI examination with high intensity magnet
70.4
6.4
7
*
Z42.2
ICD-10 Finland
Follow-up care involving plastic surgery of other parts of trunk
70.4
6.4
7
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
6.4
77
398
9474
FHL
Soft tissue tumor removal (subcutaneous tumor 9736 skin tumor 9733)
14.5
6.4
10
7
WX002
NOMESCO Finland
Sedation and analgesia
1.7
6.3
136
863
TJF80
NOMESCO Finland
Ostomy education
18.2
6.3
9
5
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
6.3
6
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
6.3
6
*
C49.54
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis rhabdomyosarcoma
+∞
6.3
6
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
6.3
6
*
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
+∞
6.3
6
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
6.3
6
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
6.3
6
*
C49.91
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue malignant fibrotic histiocytoma
+∞
6.3
6
*
WX1BG
NOMESCO Finland
Total body MRI with high intensity magnet
+∞
6.3
6
*
C49.33
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the chest leiomyosarcoma
+∞
6.3
6
*
DM1CG
NOMESCO Finland
Paranasal sinuses and face area extensive MRI examination with high intensity magnet
+∞
6.3
6
*
C40.2
ICD-10 Finland
Malignant neoplasm: Long bones of lower limb
+∞
6.3
6
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
6.3
6
*
Y77
ICPC
Malignant neoplasm prostate
+∞
6.3
6
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
6.3
6
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
6.3
6
*
C49.35
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thoracic fibrosarcoma
+∞
6.3
6
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
6.3
6
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
6.3
6
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
6.3
6
*
C49.40
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen without histology
+∞
6.3
6
*
8890/3-C49.6
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
6.3
6
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
6.3
6
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
6.3
6
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
8850/3-C49.5
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of pelvis
+∞
6.3
6
*
NC1CG
NOMESCO Finland
Elbow and forearm extensive MRI examination with high intensity magnet
26.9
6.2
8
*
TQD05
NOMESCO Finland
Puncture of skin of lower limb
26.9
6.2
8
*
D21.1
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
6.4
6.2
15
24
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.3
6.2
21
50
XX9XW
NOMESCO Finland
NA
12.6
6.1
10
8
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.4
6.1
20
46
S04
ICPC
Lump/swelling localized
2.1
6.1
62
302
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.3
6.0
28
87
ZXC96
NOMESCO Finland
Robot assisted procedure
10.1
6.0
11
11
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
5.2
6.0
17
33
D64.9
ICD-10 Finland
Anaemia, unspecified
2.0
6.0
78
417
NG4AA
NOMESCO Finland
Lower leg X-ray examination
3.2
6.0
29
93
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
520
335
23.04
307.65
1.5
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
852
3708
3.94
152.60
2.9
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
368
881
5.19
148.10
1.5
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
760
3305
3.59
131.21
3.5
2.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
280
591
5.58
129.16
3.5
1.4
ug/l
9.0
3.6
0.86
213
440
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
408
1181
4.35
127.87
6.1
2.8
u/l
279.2
236.5
1.27
398
1109
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
72
14
53.93
126.02
1.2
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
635
2565
3.53
121.25
3.3
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
966
5044
3.50
121.15
5.2
3.7
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
495
1707
3.81
120.45
5.7
2.8
mmol/l
0.8
0.8
1.93
480
1570
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1029
5722
3.45
113.51
12.8
3.8
umol/l
11.4
12.4
1.13
1001
5344
(3024561) Albumin [Mass/volume] in Serum or Plasma
891
4922
2.95
92.07
8.4
3.8
g/l
34.2
35.7
11.50
850
4518
(3033658) Prothrombin time (PT) actual/Normal
611
2783
2.99
89.89
5.8
3.5
%
89.0
86.2
2.12
599
2703
(3013650) Neutrophils [#/volume] in Blood by Automated count
1048
6417
3.02
87.69
17.9
6.4
e9/l
4.1
4.3
2.51
948
5502
(40768795) Lymph node Pathology biopsy report
61
25
25.38
86.63
1.4
1.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
653
3149
2.88
85.54
5.6
4.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
140
226
6.72
84.21
2.9
1.8
u/ml
159.1
64.9
0.51
115
180
(3015377) Calcium [Moles/volume] in Serum or Plasma
717
3709
2.76
80.96
8.1
2.1
mmol/l
2.3
2.4
0.65
650
3083
(40758558) Short blood count panel - Blood
568
2733
2.72
72.22
14.6
4.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
888
5339
2.59
70.67
8.9
5.5
mmol/l
1.2
1.2
1.06
838
4732
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
939
5893
2.54
66.71
9.8
5.8
mmol/l
1.2
1.2
2.44
807
4981
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
469
2145
2.71
64.79
5.7
2.2
mmol/l
2.5
2.4
2.48
430
1843
(3032080) INR in Blood by Coagulation assay
819
4904
2.45
63.30
9.0
10.2
inr
1.2
1.3
2.93
209
1383
(3003458) Phosphate [Moles/volume] in Serum or Plasma
372
1542
2.87
61.76
6.8
5.2
mmol/l
1.0
1.0
0.98
358
1411
(3042936) Bacteria identified in Isolate by Culture
382
1639
2.78
59.13
2.1
2.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
684
3869
2.39
58.88
7.4
5.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
624
3407
2.41
58.00
6.9
3.2
ph
7.4
7.4
0.84
123
575
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1217
8993
2.75
55.96
14.8
5.4
u/l
85.2
76.8
5.63
1179
8304
(3022096) Basophils/100 leukocytes in Blood
811
5211
2.19
48.37
8.3
5.7
%
0.6
0.7
0.86
775
4816
(3021879) Hepatitis B virus core Ab [Presence] in Serum
197
651
3.33
47.80
1.3
1.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
842
5513
2.18
47.57
8.4
5.7
%
24.4
27.6
12.18
801
5086
(3019069) Monocytes/100 leukocytes in Blood
827
5385
2.17
47.29
8.6
5.9
%
9.1
8.7
2.30
790
4998
(3006504) Eosinophils/100 leukocytes in Blood
818
5366
2.13
45.12
8.4
5.7
%
2.8
3.0
0.82
779
4954
(3001604) Monocytes [#/volume] in Blood
860
5768
2.13
44.52
8.0
5.4
e9/l
0.6
0.6
0.78
755
4920
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
279
1174
2.68
43.68
3.1
2.2
umol/l
9.5
8.2
0.39
250
1013
(3006315) Basophils [#/volume] in Blood
859
5802
2.10
43.11
8.1
5.4
e9/l
0.0
0.0
4.00
754
4953
(3018010) Neutrophils/100 leukocytes in Blood
822
5471
2.09
42.81
8.1
5.6
%
59.5
57.5
4.41
788
5074
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
81
148
5.72
42.67
1.2
1.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
322
1472
2.51
42.39
8.3
6.2
mmol/l
105.2
104.3
3.23
313
1433
(3019198) Lymphocytes [#/volume] in Blood
869
5921
2.09
42.27
8.1
5.5
e9/l
1.7
1.9
5.12
776
5147
(3007853) Bacteria identified in Skin by Aerobe culture
304
1357
2.55
42.07
1.9
1.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
557
3232
2.14
41.51
3.4
3.0
e6/l
0.7
0.4
0.82
418
2418
(3020779) Urea [Moles/volume] in Serum or Plasma
252
1032
2.73
41.48
8.2
6.6
mmol/l
8.3
10.4
4.63
245
978
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
227
888
2.83
40.76
2.2
2.0
g/l
0.2
0.2
0.23
220
806
(3013115) Eosinophils [#/volume] in Blood
872
6001
2.06
40.64
8.5
5.6
e9/l
0.2
0.2
0.48
773
5212
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
175
599
3.17
39.82
9.4
9.3
mmol/l
24.2
24.3
0.08
170
552
(3045142) Bone marrow Pathology biopsy report
56
78
7.42
38.31
1.2
1.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
978
7101
2.05
38.28
6.5
4.5
mmol/l
6.8
6.8
0.01
950
6614
(3002582) Erythrocytes [#/volume] in Urine
580
3516
2.05
37.63
3.4
3.1
e6/l
52.1
93.0
0.84
440
2677
(36304419) Bacteria [Presence] in Urine
529
3130
2.06
36.44
3.3
2.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
236
1007
2.59
35.46
9.4
7.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
290
1378
2.36
34.44
7.8
7.3
mmol/l
0.4
1.2
2.29
239
1064
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
290
1383
2.35
34.13
7.8
7.3
kpa
5.2
5.1
1.00
282
1324
(3027801) Oxygen [Partial pressure] in Arterial blood
290
1383
2.35
34.13
7.8
7.3
kpa
14.2
11.5
11.53
280
1321
(3021589) Normoblasts [#/volume] in Blood
756
5147
1.93
34.09
14.5
8.4
e9/l
0.0
0.0
0.10
638
4153
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
41
45
9.34
33.99
2.0
2.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
49
68
7.41
33.61
2.0
1.9
e9/l
0.8
1.3
1.88
35
34
(3017143) Hepatitis C virus Ab [Presence] in Serum
240
1064
2.49
33.15
1.6
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
193
772
2.72
32.90
1.6
1.6
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
42
51
8.44
32.20
1.9
2.0
%
16.2
13.5
0.42
20
27
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
117
356
3.48
32.06
2.6
3.0
u/ml
0.3
0.4
0.11
75
199
(3020630) Protein [Mass/volume] in Serum or Plasma
225
989
2.50
31.57
5.7
1.6
g/l
64.8
67.2
4.66
214
894
(3018677) aPTT in Platelet poor plasma by Coagulation assay
346
1838
2.14
31.04
2.6
2.0
s
30.0
30.0
0.04
332
1774
(3018095) Leukocytes [#/volume] in Urine
631
4138
1.90
31.03
3.9
3.5
e6/l
173.4
106.4
0.51
460
2893
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
360
1946
2.11
30.84
2.2
1.8
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
243
1130
2.37
30.03
8.8
7.9
g/l
117.5
122.6
3.71
237
1092
(3003694) ABO and Rh group [Type] in Blood
480
2921
1.94
29.27
1.4
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
560
3592
1.88
29.03
5.6
2.6
u/l
33.3
35.4
0.38
538
3408
(3004809) Band form neutrophils/100 leukocytes in Blood
62
128
5.01
28.51
2.8
2.9
%
2.3
1.4
0.87
54
90
(3016502) Oxygen saturation in Arterial blood
253
1234
2.26
27.83
8.4
7.7
%
96.3
94.9
2.49
246
1188
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
152
600
2.70
26.42
9.4
11.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
45
74
6.24
26.36
1.3
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
330
1822
2.04
26.23
3.0
2.8
e6/l
2.1
2.5
0.28
176
959
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
97
300
3.39
25.87
1.7
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
350
1987
1.99
25.66
2.9
2.6
e6/l
1.1
1.3
0.27
196
1122
(3026493) Urate [Moles/volume] in Serum or Plasma
498
3177
1.84
25.57
4.2
2.4
umol/l
3473.0
6596.7
1.04
452
2715
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
249
1247
2.19
25.53
1.5
1.6
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
55
113
5.01
25.44
2.3
1.6
u/ml
7.4
41.3
0.48
55
107
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
70
176
4.12
25.21
4.2
5.5
iu/ml
163.9
572.4
—
9
22
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
262
1366
2.11
24.14
1.9
1.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
208
989
2.28
24.13
2.7
2.1
u/l
47.2
89.0
0.38
183
818
(3008757) Leukocyte morphology finding [Identifier] in Blood
48
92
5.35
24.00
2.4
3.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
55
119
4.76
23.94
2.0
1.8
u/ml
23.7
49.4
0.66
50
107
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
261
1367
2.10
23.73
2.0
1.7
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
21
14
15.20
23.67
2.1
3.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
235
1185
2.16
23.57
4.8
3.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
65
165
4.07
23.11
2.1
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
378
2287
1.87
22.53
2.9
2.6
mosm/kgh2o
542.2
549.7
0.26
320
1905
(3042111) Morphology [Interpretation] in Bone marrow Narrative
61
152
4.14
22.24
1.3
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
397
2458
1.83
21.90
2.7
2.4
e6/l
5.6
5.3
0.17
336
2126
(3004789) Transferrin [Mass/volume] in Serum or Plasma
299
1690
1.96
21.85
2.3
2.4
g/l
2.2
2.3
2.08
284
1566
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
77
230
3.47
21.68
2.0
1.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
977
7794
1.71
21.23
4.7
4.4
e6/l
160.3
2555.6
2.13
13
102
(3017181) Myelocytes/100 leukocytes in Blood
184
877
2.25
21.12
4.6
4.0
%
1.3
0.7
2.86
95
200
(21494814) CD8 cells/100 lymphocytes in Specimen
22
21
10.61
20.03
2.1
2.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
76
237
3.32
20.01
2.0
1.5
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
26
9
29.36
19.66
2.3
1.0
u/ml
14.7
16.9
—
26
9
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
272
1553
1.91
19.07
2.5
2.6
%
22.6
23.3
0.31
242
1312
(3022948) Iron [Moles/volume] in Serum or Plasma
309
1850
1.84
18.65
2.5
2.4
umol/l
12.7
13.3
0.53
288
1700
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
16
10
16.16
18.52
6.3
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
172
842
2.18
18.41
4.7
4.0
%
0.2
0.1
1.30
89
180
(46235355) HIV 1 and 2 tests - Meaningful Use set
267
1537
1.89
18.20
1.6
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
67
207
3.34
17.91
1.4
1.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
33
62
5.42
16.88
1.8
1.7
e6/l
286.1
852.1
—
8
25
(3002179) Metamyelocytes/100 leukocytes in Blood
162
805
2.13
16.65
4.7
3.9
%
1.0
0.5
1.14
73
148
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1340
12027
1.94
15.98
26.8
13.0
mg/l
31.1
24.0
10.49
1200
9330
(3027945) Reticulocytes/100 erythrocytes in Blood
244
1432
1.84
15.48
2.0
2.2
%
1.8
1.8
0.06
221
1258
(3005719) IgG [Mass/volume] in Serum or Plasma
155
792
2.07
14.77
3.6
2.3
g/l
9.3
10.7
3.46
143
730
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
29
55
5.36
14.69
1.8
1.5
e9/l
0.2
0.2
0.35
22
47
(3000060) B lymphocytes [#/volume] in Blood
18
20
9.10
14.68
1.5
1.8
e6/l
760.0
364.5
—
9
11
(3002385) Erythrocyte distribution width [Ratio]
1135
9801
1.62
14.59
32.7
15.6
%
14.2
13.7
20.64
1117
9553
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
49
142
3.53
14.49
5.6
6.8
mg/l
12.2
11.8
0.21
43
132
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
29
57
5.17
14.13
1.8
1.6
e6/l
518.1
427.2
0.41
22
47
(3044889) 12 lead EKG panel
1013
8555
1.55
14.01
4.3
4.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
154
801
2.03
13.97
4.7
4.1
%
0.0
0.6
0.50
76
154
(3026008) Bacteria identified in Urine by Culture
495
3594
1.56
13.80
3.2
3.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
17
19
9.04
13.79
1.3
1.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
144
735
2.06
13.75
2.0
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
27
51
5.37
13.74
1.2
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
35
83
4.29
13.66
1.3
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
41
110
3.80
13.57
1.9
1.6
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
43
120
3.66
13.46
1.4
1.5
e6/l
1034.6
1869.6
1.82
28
86
(3012441) Differential panel - Pleural fluid
39
102
3.90
13.38
1.4
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
499
3661
1.54
13.14
2.6
2.3
u/l
56.8
57.5
0.11
464
3347
(3028308) Erythrocytes [#/volume] in Pleural fluid
40
108
3.78
13.13
1.4
1.6
e6/l
37281.9
91987.6
0.45
23
65
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
27
54
5.07
12.91
1.2
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
33
79
4.25
12.74
1.1
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
63
232
2.79
12.51
1.4
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
21
34
6.25
12.48
1.9
2.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
16
20
8.07
11.89
1.3
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
184
1072
1.81
11.82
2.2
2.3
e9/l
69.7
68.9
0.08
134
809
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
161
906
1.87
11.55
7.6
2.8
mmol/l
1.2
1.2
0.39
145
754
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
44
140
3.21
11.29
1.8
1.4
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
95
447
2.20
11.19
2.3
2.2
ug/l
335.7
494.4
0.67
86
416
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
84
376
2.31
11.15
2.0
2.9
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
63
250
2.59
10.85
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
63
250
2.59
10.85
1.4
1.4
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
13
14
9.36
10.77
1.0
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
121
634
1.99
10.74
2.3
1.4
g/l
0.9
1.2
1.46
110
583
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
121
635
1.98
10.69
5.7
4.0
mmol/l
24.3
24.2
0.13
111
562
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
49
173
2.89
10.55
1.7
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
35
101
3.52
10.47
1.4
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
30
78
3.90
10.41
2.0
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
18
30
6.06
10.40
2.8
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
18
30
6.06
10.40
2.8
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
18
30
6.06
10.40
2.8
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
24
53
4.58
10.26
2.6
2.4
%
39.4
44.6
—
5
20
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
13
15
8.73
10.24
4.3
6.9
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
13
15
8.73
10.24
2.2
3.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
129
705
1.91
10.12
1.4
1.5
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
32
89
3.65
10.11
3.6
3.0
%
58.8
54.0
0.55
25
54
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
40
130
3.13
9.95
1.7
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1362
12641
1.72
9.81
28.4
15.7
mmol/l
139.3
139.7
7.36
1338
12284
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
32
91
3.57
9.80
1.2
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
18
32
5.68
9.76
1.6
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
956
8256
1.42
9.73
4.5
4.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
29
78
3.77
9.62
2.0
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1243
11298
1.54
9.62
25.7
11.9
ml/min/173m2
80.1
77.9
2.93
1124
9074
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
20
40
5.05
9.58
4.8
1.1
u/ml
13.7
65.2
—
6
10
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
22
49
4.54
9.32
2.0
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
22
49
4.54
9.32
2.0
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1362
12677
1.70
9.24
28.9
15.8
mmol/l
4.0
4.0
4.21
1338
12295
(40760892) CBC W Ordered Manual Differential panel - Blood
336
2418
1.50
9.17
5.4
4.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
59
4.12
8.99
1.9
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
346
2514
1.49
8.99
2.1
1.7
mg/l
1.9
1.2
1.48
279
1907
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
20
43
4.70
8.83
2.7
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
20
43
4.70
8.83
2.7
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
20
43
4.70
8.83
2.7
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
20
43
4.70
8.83
2.7
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
42
151
2.83
8.79
1.6
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
341
2481
1.48
8.78
3.5
3.9
ng/l
198.7
543.2
2.89
287
2023
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
39
135
2.94
8.74
1.7
1.4
—
—
—
0
0
(4281824)
22
52
4.28
8.67
1.2
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
152
916
1.73
8.66
4.8
3.7
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
21
48
4.42
8.63
2.6
1.2
ug/l
1.7
3.4
1.02
11
43
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
90
460
2.02
8.59
2.1
1.8
ug/l
1.0
1.7
0.63
78
398
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
32
101
3.21
8.38
2.3
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
15
27
5.60
8.03
1.1
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
11
14
7.91
7.99
1.3
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1185
10788
1.44
7.94
29.1
14.6
%
38.0
39.8
10.17
855
7308
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
72
349
2.12
7.93
1.2
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
12
8
15.10
7.72
1.9
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1338
12525
1.56
7.36
21.6
12.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
33
115
2.91
7.35
2.2
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
18
42
4.32
7.22
1.1
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
400
3096
1.40
7.18
2.1
2.2
mg/l
3.0
2.9
0.20
336
2590
(3052851) Hemolysis interference index of Serum or Plasma
70
351
2.04
7.08
3.8
3.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
47
200
2.39
7.08
4.1
3.2
%
62.3
58.3
1.22
47
200
(40768443) Skin Pathology biopsy report
86
464
1.90
7.07
1.2
1.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
184
1227
1.57
7.04
4.8
3.5
kpa
5.7
5.8
0.65
178
1184
(3001964) Herpes simplex virus Ag [Presence] in Specimen
14
27
5.22
6.97
1.4
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
16
35
4.61
6.94
2.8
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
487
3912
1.36
6.91
3.2
3.1
ng/l
1927.8
1469.5
1.24
431
3342
(3012501) Base excess in Blood by calculation
53
242
2.23
6.81
4.4
4.1
mmol/l
2.7
2.7
0.01
43
158
(3002032) Base excess in Venous blood by calculation
182
1222
1.56
6.76
4.8
3.5
mmol/l
1.7
1.9
0.51
149
966
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
15
32
4.72
6.69
2.5
2.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
53
244
2.21
6.68
2.6
3.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
47
207
2.31
6.58
2.8
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1001
8971
1.34
6.56
4.2
4.1
mm/h
16.0
12.1
7.50
907
8258
(3004588) Protein electrophoresis panel - Serum or Plasma
135
852
1.64
6.49
4.4
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
86
484
1.82
6.23
2.8
1.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
584
4884
1.32
6.13
2.7
2.8
ug/l
257.8
132.4
2.61
548
4461
(21494890) Protein electrophoresis panel - 24 hour Urine
28
99
2.86
6.11
4.0
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
195
1361
1.50
6.04
1.7
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
44
196
2.28
6.03
3.7
3.0
e9/l
4.5
4.3
0.18
44
196
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
93
546
1.75
5.86
1.4
1.7
g/l
2.0
1.5
2.52
81
473
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
45
205
2.23
5.86
1.8
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
25
85
2.97
5.85
2.4
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
25
85
2.97
5.85
2.4
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
25
85
2.97
5.85
2.4
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
41
180
2.31
5.82
1.5
2.0
u/l
212.4
2334.8
—
9
74
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
24
80
3.03
5.81
1.4
1.5
nmol/l
0.2
0.4
2.33
18
67
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
54
267
2.06
5.73
1.3
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
128
823
1.61
5.73
4.3
5.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1160
12373
0.74
5.68
4.7
5.2
mmol/l
2.7
2.7
0.02
1037
11332
(3035637) Corticotropin [Mass/volume] in Plasma
27
98
2.79
5.64
1.4
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
57
290
2.00
5.60
1.2
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1132
12108
0.75
5.55
4.2
4.6
mmol/l
4.5
4.6
0.40
1014
11138
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1358
12893
1.49
5.49
17.9
9.1
u/l
26.3
26.3
0.03
1320
12342
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1123
12016
0.75
5.43
4.1
4.6
mmol/l
1.4
1.4
2.97
994
10978
(3035880) pH of Pleural fluid
18
53
3.42
5.31
1.1
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
19
58
3.30
5.31
4.6
3.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
63
341
1.88
5.20
4.7
1.4
g/l
0.0
0.0
0.00
58
316
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
78
452
1.76
5.17
4.1
1.4
g/l
3.4
3.1
1.34
61
361
(3023323) Follitropin [Units/volume] in Serum or Plasma
55
285
1.96
5.16
1.5
1.3
iu/l
31.0
26.1
0.39
43
246
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
66
365
1.84
5.10
4.6
1.4
g/l
0.5
0.0
0.80
61
337
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
63
344
1.87
5.07
4.7
1.4
g/l
0.0
0.0
0.00
58
317
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
72
411
1.79
5.03
4.7
1.4
g/l
2.5
0.4
1.37
64
356
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
66
368
1.83
4.98
7.0
1.5
mg/l
48.7
49.5
0.01
55
291
(3034860) Kappa light chains.free [Mass/volume] in Serum
66
369
1.82
4.94
6.9
1.4
mg/l
42.7
45.3
0.07
55
293
(3009214) Lutropin [Units/volume] in Serum or Plasma
47
234
2.04
4.94
1.7
1.4
u/l
11.2
9.0
0.47
37
190
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
43
208
2.10
4.87
1.8
1.4
—
15.1
—
0
8
(3022145) Colonoscopy Study observation
160
1124
1.47
4.81
1.4
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
48
244
2.00
4.77
2.9
2.3
%
15.5
16.4
0.47
20
127
(3042631) Mycobacterium sp identified in Specimen
31
132
2.38
4.75
2.0
2.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
68
389
1.78
4.73
4.5
1.4
g/l
37.7
37.8
0.04
61
334
(40760888) Immunoglobulin light chains.free panel - Serum
51
267
1.94
4.67
6.9
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
81
489
1.69
4.67
4.0
1.4
g/l
7.6
7.5
0.16
63
367
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
81
489
1.69
4.67
4.0
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
81
489
1.69
4.67
4.0
1.4
g/l
4.0
3.9
0.12
61
357
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
25
97
2.60
4.65
1.1
1.2
u/l
55.7
51.1
0.29
18
71
(40768797) Stomach Pathology biopsy report
214
1598
1.39
4.61
1.3
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
140
967
1.49
4.58
4.6
2.3
ml/min/173m2
59.9
66.0
0.86
55
398
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
38
182
2.12
4.44
1.7
1.5
u/ml
90.1
103.3
—
9
34
(3021601) Nitrite [Presence] in Urine by Test strip
667
5855
1.25
4.30
4.9
5.0
estimate
0.0
0.0
0.50
147
1012
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
94
605
1.59
4.25
4.1
3.0
pmol/l
4.5
4.5
0.08
85
513
(40761539) Cells [Type] in Urine sediment by Light microscopy
11
27
4.10
4.16
1.0
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
26
109
2.41
4.15
4.2
3.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
27
118
2.31
3.95
1.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
73
450
1.65
3.94
2.4
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1093
11607
0.79
3.88
3.8
4.1
mmol/l
1.3
1.3
1.20
958
10518
(3035350) Ketones [Presence] in Urine by Test strip
661
5845
1.23
3.85
3.6
3.7
estimate
0.0
0.0
0.00
152
1002
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
74
461
1.64
3.84
4.2
1.4
g/l
10.5
10.5
0.00
64
394
(3009261) Glucose [Presence] in Urine by Test strip
669
5927
1.23
3.82
3.7
3.7
estimate
0.0
0.0
0.80
144
981
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
5
12.04
3.76
1.2
1.0
—
—
—
0
0
(44790048)
27
122
2.23
3.68
1.4
1.6
—
—
—
0
0
(44806118)
27
122
2.23
3.68
1.4
1.6
—
—
—
0
0
(44790047)
27
122
2.23
3.68
1.4
1.6
—
—
—
0
0
(44790049)
27
122
2.23
3.68
1.4
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
223
1739
1.33
3.65
25.8
27.2
inr
1.5
1.4
0.33
21
243
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
114
796
1.47
3.58
3.7
4.4
mmol/l
2.7
1.7
1.78
87
571
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
18
68
2.67
3.57
1.4
2.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
8
13
6.18
3.50
1.0
2.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
21
88
2.41
3.40
3.0
2.5
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
9
18
5.02
3.37
2.3
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
366
3078
1.25
3.31
1.5
1.5
nmol/l
20.0
20.6
0.30
322
2575
(3025468) Yersinia sp identified in Specimen by Organism specific culture
27
128
2.13
3.31
1.5
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
156
1172
1.37
3.27
2.4
3.1
ng/l
220.2
214.5
0.06
139
1074
(3008152) Bicarbonate [Moles/volume] in Arterial blood
113
803
1.44
3.26
6.7
7.3
mmol/l
25.0
24.6
0.60
106
751
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
20
85
2.37
3.16
1.6
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
33
172
1.94
3.15
1.3
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
115
826
1.42
3.14
3.7
4.4
ph
7.4
7.4
0.82
15
91
(3024354) Oxygen [Partial pressure] in Venous blood
138
1026
1.38
3.09
4.5
3.0
kpa
4.6
4.6
0.01
131
985
(3028433) Virus identified in Specimen by Culture
12
39
3.09
3.09
1.1
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
8
7.52
3.05
1.8
2.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
50
300
1.69
3.05
1.2
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
27
133
2.05
3.02
1.4
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
7
12
5.85
3.02
1.0
1.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
26
127
2.07
2.98
1.5
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
86
591
1.48
2.97
1.3
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
27
134
2.03
2.97
1.5
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
27
134
2.03
2.97
1.5
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
42
242
1.76
2.96
1.3
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
42
243
1.75
2.92
1.0
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
26
129
2.03
2.87
1.5
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
61
393
1.58
2.84
2.9
1.8
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
127
951
1.37
2.74
3.5
4.0
ng/l
95.9
91.1
0.29
107
822
(3000963) Hemoglobin [Mass/volume] in Blood
1387
13459
1.34
2.72
38.5
19.2
g/l
128.2
136.3
59.76
1371
13211
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
59
886
0.65
2.68
1.8
1.9
—
—
—
0
0
(3024731) MCV [Entitic volume]
1386
13455
1.33
2.65
38.2
19.0
fl
91.3
91.2
0.40
1367
13207
(3035941) MCH [Entitic mass]
1386
13456
1.33
2.64
38.2
18.9
pg
30.3
30.4
2.09
1367
13209
(3023419) Bacteria identified in Sputum by Culture
30
162
1.87
2.63
2.4
2.7
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1386
13457
1.33
2.63
38.3
19.0
e12/l
4.3
4.5
39.87
1352
12980
(3019225) pH of Specimen
153
1189
1.32
2.60
5.2
3.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1386
13460
1.33
2.60
38.4
19.1
e9/l
6.9
6.8
0.79
1349
12982
(3007461) Platelets [#/volume] in Blood
1385
13449
1.32
2.60
38.4
19.0
e9/l
249.4
246.1
0.94
1351
13024
(3011397) Hemoglobin [Presence] in Urine by Test strip
339
2900
1.22
2.56
3.2
3.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
53
805
0.65
2.55
1.8
1.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
21
101
2.09
2.53
2.5
2.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
44
271
1.64
2.49
1.7
2.0
iu/l
5.0
4.8
0.03
16
94
(3044007) Cell count panel - Peritoneal fluid
8
21
3.82
2.46
3.0
2.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
20
96
2.10
2.43
1.1
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
24
125
1.93
2.36
1.0
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
152
1907
0.77
2.34
1.2
1.2
u/ml
13.2
11.4
0.11
50
719
(3036481) Cortisol [Moles/volume] in Serum or Plasma
135
1047
1.32
2.34
2.3
1.8
nmol/l
376.4
363.1
0.32
125
943
(3017446) Testosterone [Moles/volume] in Serum or Plasma
102
764
1.36
2.24
2.4
2.2
nmol/l
11.8
14.6
3.32
92
671
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
31
181
1.73
2.16
3.3
2.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
51
339
1.52
2.13
1.7
1.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1069
10169
1.17
2.13
34.8
17.2
g/l
330.6
332.6
10.84
1057
10088
(3021901) Oxygen saturation in Capillary blood
37
228
1.64
2.12
2.4
2.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
448
3994
1.17
2.11
2.7
2.2
u/l
152.7
240.0
2.34
423
3735
(3038177) Helicobacter pylori Ab [Presence] in Serum
28
160
1.76
2.10
1.4
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
96
1262
0.74
2.10
1.7
1.6
—
—
—
0
0
(3000012) Reticulocyte production index
14
62
2.27
2.08
1.4
1.9
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
5
10
5.01
2.07
6.2
1.5
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
10
5.01
2.07
6.0
1.5
—
—
—
0
0
(3013512) EKG study
408
3617
1.17
2.05
4.2
4.0
—
—
—
0
0
(3020891) Body temperature
73
527
1.40
2.03
4.0
4.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
8
26
3.09
2.01
2.1
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
539
4899
1.16
1.95
2.2
2.3
nmol/l
77.2
77.7
0.14
468
4285
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
209
2468
0.82
1.89
1.2
1.2
u/ml
1.0
1.9
1.25
38
666
(3048879) Bone marrow aspiration report
8
28
2.87
1.86
2.6
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
23
129
1.79
1.86
5.0
4.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
801
7502
1.14
1.85
3.5
3.0
u/l
58.0
48.3
1.37
752
6886
(3002619) Bacteria identified in Specimen by Culture
6
17
3.54
1.84
1.0
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
354
3982
0.86
1.83
2.9
3.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
16
80
2.01
1.80
2.9
2.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1159
11999
0.86
1.78
4.6
4.8
mmol/l
6.0
6.0
0.07
1029
10844
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
11
47
2.35
1.78
1.5
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
11
47
2.35
1.78
1.5
1.2
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
14
67
2.10
1.76
1.4
1.6
—
12.5
—
0
5
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
14
67
2.10
1.76
1.1
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
17
88
1.94
1.75
2.0
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
62
843
0.72
1.73
1.5
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
30
2.68
1.72
1.1
1.3
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
7
24
2.93
1.72
1.0
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
13
61
2.14
1.71
1.5
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
13
61
2.14
1.71
1.6
1.5
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
13
3.85
1.71
1.2
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
18
96
1.89
1.71
1.1
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
11
48
2.30
1.70
2.0
2.2
u/l
177.7
204.8
1.60
11
48
(3016650) Hepatitis A virus Ab [Presence] in Serum
29
179
1.63
1.70
1.2
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
40
268
1.51
1.67
2.0
2.1
g/l
121.7
131.8
1.09
25
201
(3024471) HLA-A [Type]
8
31
2.59
1.66
1.0
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
13
62
2.11
1.65
1.5
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
105
1312
0.79
1.61
1.5
1.7
%
1.4
1.5
1.01
92
1134
(3043409) Potassium [Moles/volume] in Arterial blood
55
396
1.40
1.60
3.6
4.2
mmol/l
3.8
3.9
0.34
49
372
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
20
3.01
1.58
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
234
0.51
1.56
1.1
1.3
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
16
85
1.89
1.55
3.6
1.7
—
2.1
—
0
8
(3048929) Epstein Barr virus Ab [Presence] in Serum
43
298
1.46
1.54
1.4
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
353
3162
1.15
1.53
4.2
4.0
estimate
0.0
0.0
0.88
137
981
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
15
3.34
1.52
1.4
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
43
0.00
1.52
0.0
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
32
210
1.54
1.49
1.5
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
54
394
1.38
1.48
4.5
2.8
g/l
0.2
0.3
0.39
37
137
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1109
11471
0.88
1.47
5.7
6.2
mmol/mol
40.1
40.4
0.64
995
10581
(3032057) Clostridioides difficile [Presence] in Stool
7
28
2.51
1.45
1.4
2.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
20
117
1.72
1.45
1.1
1.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
77
596
1.31
1.44
3.5
2.5
%
0.6
0.6
0.29
69
570
(3033799) Differential panel - Peritoneal fluid
6
22
2.73
1.43
3.3
1.9
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
24
149
1.62
1.41
1.1
1.2
u/ml
2.7
6.5
—
9
70
(3039443) Prostate specific Ag panel - Serum or Plasma
12
225
0.53
1.40
1.4
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
79
619
1.29
1.37
4.3
4.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
40
282
1.43
1.34
1.1
1.3
e6/l
912.5
1102.8
0.09
33
232
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
37
0.00
1.34
0.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
12
61
1.97
1.33
1.1
1.0
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
40
283
1.42
1.32
1.1
1.3
e6/l
29.6
38.2
0.11
31
224
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
8
34
2.36
1.29
1.6
1.7
iu/ml
—
1742191.7
—
0
6
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
19
114
1.68
1.28
1.1
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
40
285
1.41
1.28
2.3
2.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
44
2.05
1.27
2.9
3.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
170
1968
0.85
1.26
1.2
1.3
iu/ml
35.7
38.7
0.09
54
619
(3024928) Oxygen saturation in Venous blood
39
278
1.41
1.25
5.8
3.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
953
9144
1.11
1.24
4.0
3.8
pmol/l
14.8
14.9
0.25
851
8221
(4306422)
23
147
1.57
1.23
1.3
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
29
196
1.49
1.22
1.3
1.3
u/ml
264.9
232.2
0.21
16
115
(3034426) Prothrombin time (PT)
8
37
2.17
1.21
1.3
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
6
26
2.31
1.18
1.0
1.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
42
307
1.38
1.18
1.4
1.5
ug/g
215.6
295.9
1.82
28
173
(3019150) Specific gravity of Urine by Refractometry
245
2741
0.87
1.16
3.7
4.0
kg/l
1.0
1.0
0.91
38
404
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
(4268621)
17
103
1.66
1.13
2.1
2.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
23
151
1.53
1.12
1.1
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
21
135
1.56
1.11
1.0
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
388
4205
0.90
1.10
3.9
4.0
mg/mmol
6.1
12.2
0.78
244
2654
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
152
1.52
1.09
1.0
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
66
1.82
1.09
1.1
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
7
32
2.19
1.08
1.7
1.5
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
97
805
1.22
1.07
4.0
3.0
g/l
122.2
130.6
3.38
92
780
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
26
178
1.47
1.05
1.2
1.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
22
2.28
1.03
1.6
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
25
358
0.69
1.03
1.0
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
53
1.89
1.01
2.2
2.6
u/ml
883.8
1050.0
—
10
53
(3047007) Chlamydophila sp Ab [Presence] in Serum
23
156
1.48
0.98
1.1
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
138
1587
0.86
0.98
4.5
4.8
%
31.6
32.9
0.71
91
1039
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
14
84
1.67
0.98
1.2
1.1
u/ml
0.0
0.7
—
6
44
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
16
100
1.61
0.97
1.8
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
564
5321
1.10
0.96
1.9
2.0
pmol/l
92.0
93.7
0.35
306
2722
(3001019) Free T4 and TSH panel - Serum or Plasma
33
443
0.74
0.94
1.3
1.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1137
11084
1.10
0.91
4.7
4.6
mu/l
1.9
2.1
0.80
1016
10044
(3011648) Oxygen content in Venous blood
17
110
1.55
0.90
8.4
2.6
%
11.2
11.0
0.05
17
110
(37021550) Renin [Units/volume] in Plasma --upright
6
29
2.07
0.89
1.7
1.2
mu/l
49.8
74.8
—
6
21
(3050129) First trimester maternal screen panel - Serum or Plasma
9
156
0.57
0.88
1.2
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
30
2.00
0.87
1.0
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
30
2.00
0.87
1.3
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
27
367
0.73
0.85
1.3
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
21
145
1.45
0.85
1.0
1.3
nmol/l
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
64
525
1.23
0.83
1.8
1.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
22
154
1.43
0.83
1.0
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
76
903
0.83
0.82
1.2
1.2
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
6
32
1.88
0.82
1.3
3.6
mmol/l
1.2
1.2
—
6
32
(3043410) Blood group antigens tested for on Red Blood Cells
6
32
1.88
0.82
2.0
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
24
172
1.40
0.81
1.6
1.8
g/l
0.8
1.0
0.32
19
136
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.7
—
158.6
—
0
24
(3044927) Protein electrophoresis panel - Urine
9
149
0.60
0.79
1.1
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
15
98
1.54
0.78
2.0
1.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
490
4635
1.08
0.77
4.8
3.8
ug/l
2.8
2.0
1.47
431
4142
(3007164) IgA [Mass/volume] in Serum or Plasma
233
2129
1.11
0.77
1.8
1.3
g/l
2.4
2.6
0.20
153
1246
(3017732) Neutrophils [#/volume] in Blood
90
771
1.18
0.77
2.7
3.1
e9/l
4.3
4.2
0.16
71
567
(3042733) HLA Ab [Presence] in Serum
6
34
1.77
0.76
6.3
4.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
34
1.77
0.76
1.2
2.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
34
1.77
0.76
1.2
2.6
—
—
—
0
0
(3016750) Collection duration of Urine
12
75
1.60
0.75
1.7
2.0
min
527.0
499.8
—
7
56
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
68
1.62
0.71
1.2
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
68
1.62
0.71
1.2
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
326
3041
1.09
0.71
3.9
3.3
—
—
—
0
0
(4034850)
35
444
0.78
0.71
9.0
10.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
26
1.93
0.70
1.4
1.2
—
—
—
0
0
(4146454)
10
158
0.63
0.70
1.7
2.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
30
387
0.77
0.70
1.8
1.9
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
314
3362
0.92
0.70
1.6
1.6
mmol/l
1.3
1.4
0.47
253
2799
(3000492) Spirometry study
120
1061
1.14
0.69
1.7
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
12
77
1.56
0.68
1.7
1.8
—
—
—
0
0
(3004451) EKG impression Narrative
10
61
1.64
0.68
1.1
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
18
127
1.42
0.68
1.6
1.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
12
78
1.54
0.65
1.7
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
70
1.58
0.65
1.2
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
44
1.59
0.65
1.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
44
1.59
0.65
1.0
1.1
miu/ml
1874.9
1524.5
—
7
44
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
28
360
0.77
0.65
1.5
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
376
3982
0.93
0.64
3.1
3.3
mg/l
177.1
185.3
0.02
242
2532
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
513
4897
1.07
0.63
3.8
3.8
ng/l
35.3
57.8
1.26
415
3529
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
24
313
0.76
0.62
1.5
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
75
647
1.17
0.62
3.5
3.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
26
200
1.31
0.60
2.0
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
10
151
0.66
0.59
1.1
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
8
53
1.51
0.58
1.0
1.1
iu/ml
156.7
238.6
—
8
53
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
112
0.62
0.58
1.1
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
140
1542
0.90
0.57
1.2
1.3
titre
683.5
572.3
0.19
23
342
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
34
274
1.25
0.57
1.2
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
88
0.57
0.56
1.2
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
8
55
1.46
0.56
2.4
3.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
60
1.50
0.54
1.3
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
60
1.50
0.54
1.3
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
34
276
1.24
0.54
1.2
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
39
1.54
0.53
2.3
2.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
6
97
0.62
0.52
1.2
1.4
—
298.3
—
0
12
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
18
237
0.76
0.52
1.2
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
9
132
0.68
0.52
1.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
9
132
0.68
0.52
1.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
9
133
0.67
0.52
1.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
9
133
0.67
0.52
1.0
1.4
—
—
—
0
0
(4062490)
15
109
1.38
0.51
1.7
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
41
1.47
0.50
8.2
9.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
47
399
1.18
0.49
1.8
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
10
67
1.50
0.49
1.2
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
67
1.50
0.49
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
79
699
1.14
0.49
1.8
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
77
869
0.88
0.49
1.8
1.8
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
19
145
1.31
0.49
1.2
1.0
g/l
1.5
1.5
0.14
19
129
(3038026) Centromere Ab [Units/volume] in Serum
7
107
0.65
0.48
1.1
1.1
—
74.4
—
0
6
(3005033) Fetal Nuchal fold Thickness US
7
110
0.63
0.48
1.0
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
46
1.52
0.48
1.3
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
111
0.63
0.48
1.0
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
17
128
1.33
0.47
1.1
1.3
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
21
266
0.79
0.47
1.2
1.6
nmol/l
0.6
0.8
1.14
21
215
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
10
141
0.71
0.45
1.2
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
41
349
1.18
0.43
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
19
148
1.29
0.43
1.2
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
34
404
0.84
0.43
1.7
1.7
mg/l
4.6
4.3
0.04
21
292
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
15
113
1.33
0.42
2.0
1.4
%
40.6
27.3
—
9
72
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
32
1.56
0.42
1.0
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
57
1.41
0.42
1.9
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
469
4522
1.05
0.41
4.1
3.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
176
1644
1.08
0.41
1.3
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
27
326
0.83
0.41
1.7
1.6
e6/l
19929.1
12406.3
0.41
21
240
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
22
271
0.81
0.40
1.3
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
24
292
0.82
0.39
1.7
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
26
214
1.22
0.39
1.2
1.2
u/l
18.8
19.4
0.05
19
189
(3027456) Digoxin [Moles/volume] in Serum or Plasma
35
297
1.18
0.39
2.9
3.3
nmol/l
1.0
0.8
0.41
27
231
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
61
1.31
0.39
1.0
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
31
260
1.20
0.39
2.5
3.4
mg/l
40.2
25.9
0.75
20
162
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
32
378
0.84
0.39
1.5
1.9
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
7
105
0.67
0.39
1.1
1.1
—
76.5
—
0
6
(3030981) Hyaline casts [#/volume] in Urine by Automated count
66
590
1.12
0.38
2.8
2.5
e6/l
0.9
0.2
0.79
66
571
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
36
1.39
0.38
1.2
1.1
—
—
—
0
0
(44813793)
9
67
1.35
0.38
1.1
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
37
1.35
0.37
1.0
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
29
342
0.85
0.36
2.0
2.3
ug/min
75.7
91.5
0.16
18
208
(3014765) Yersinia sp identified in Stool by Organism specific culture
40
350
1.15
0.33
1.2
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
37
322
1.15
0.32
4.1
4.4
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
6
47
1.28
0.32
45.7
25.2
ug/l
102.7
139.3
—
6
38
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
698
6835
1.04
0.31
2.8
2.7
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
97
0.72
0.31
1.4
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
97
0.72
0.31
1.1
1.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
7
97
0.72
0.31
1.0
1.3
mmol/l
45.7
34.6
—
7
85
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
53
1.32
0.31
1.1
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
18
147
1.23
0.30
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
18
148
1.22
0.29
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
40
354
1.13
0.29
1.2
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
145
1369
1.07
0.28
1.4
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
62
1.29
0.28
1.8
2.3
—
—
—
0
0
(4211845)
8
62
1.29
0.28
2.4
3.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
17
140
1.22
0.27
1.1
1.0
u/ml
2.9
2.2
0.20
11
58
(3010144) Erythrocytes [#/volume] in Synovial fluid
9
116
0.77
0.27
1.6
1.3
e6/l
90853.3
167378.2
—
9
79
(3017315) Amylase [Enzymatic activity/volume] in Urine
8
64
1.25
0.27
1.6
1.3
u/l
1037.1
450.3
—
8
59
(3023511) Choriogonadotropin [Units/volume] in Urine
13
104
1.25
0.26
1.4
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
125
1324
0.94
0.26
2.3
2.2
ug/g
179.2
152.5
0.29
107
1044
(3024263) Appearance of Synovial fluid
10
77
1.30
0.26
1.8
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
9
73
1.23
0.25
6.3
10.7
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
20
170
1.18
0.24
1.1
1.1
u/ml
2.2
2.5
—
6
75
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
22
189
1.17
0.24
1.1
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
83
0.72
0.24
1.5
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
84
0.71
0.24
1.5
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
364
3742
0.96
0.23
4.4
3.7
%
23.0
24.0
0.53
182
1794
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
13
106
1.23
0.23
1.2
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
97
1.24
0.23
1.0
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
11
88
1.25
0.22
1.8
1.6
umol/l
12.2
14.1
0.26
11
79
(3025577) Chromium [Mass/volume] in Blood
7
91
0.77
0.22
2.4
2.1
ug/l
3.5
1.9
—
7
77
(40768446) Kidney Pathology biopsy report
5
41
1.22
0.22
1.2
1.7
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
13
107
1.22
0.21
1.8
2.5
ml
590.9
597.3
—
7
73
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
160
1670
0.95
0.21
10.0
6.9
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
9.4
—
0
11
(3026480) Teichoate Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
0.6
—
0
5
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
6.0
—
0
10
(3032868) Hemoglobin electrophoresis panel in Blood
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
105
0.76
0.21
1.0
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
64
687
0.93
0.20
1.1
1.2
iu/ml
103.2
143.9
0.39
16
278
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
22
192
1.15
0.20
1.1
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
14
0.00
0.20
0.0
1.2
—
6.4
—
0
7
(3027944) Amphetamines [Presence] in Urine
26
291
0.89
0.19
1.2
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
18
156
1.16
0.18
2.2
2.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
409
4176
0.97
0.18
3.0
3.2
mmol/l
7.4
7.5
0.25
342
3502
(1002224) Polysomnography panel
42
456
0.92
0.18
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
58
1.21
0.18
1.3
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
77
815
0.94
0.18
1.4
1.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
16
138
1.16
0.17
1.3
1.3
mmol/l
8.9
7.5
—
10
96
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
71
1.13
0.16
1.1
1.2
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
10
119
0.84
0.15
2.8
3.0
mg/l
14.4
19.0
—
5
87
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
14
121
1.16
0.15
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
80
763
1.05
0.14
1.1
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
26
237
1.10
0.14
1.8
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
55
582
0.94
0.13
1.5
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
20
181
1.11
0.12
1.2
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
20
181
1.11
0.12
1.1
1.5
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
29
313
0.93
0.12
1.1
1.1
u/ml
4.2
8.6
—
6
33
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
14
157
0.89
0.11
1.9
1.5
%
65.1
64.4
—
9
105
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
11
96
1.15
0.10
1.0
1.0
mg/l
316.2
289.6
0.53
11
89
(4024509)
12
106
1.13
0.09
1.6
1.7
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
87
1.15
0.09
2.0
1.4
g/l
1.1
0.9
—
10
87
(3008401) Mugwort IgE Ab [Units/volume] in Serum
16
145
1.10
0.09
1.1
1.1
u/ml
0.2
1.0
—
7
63
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
5
48
1.04
0.09
1.6
2.2
nmol/l
2.0
9.1
—
5
39
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
6
55
1.09
0.09
2.7
2.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
110
1071
1.03
0.08
3.6
3.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
258
2620
0.98
0.08
3.2
2.7
ug/l
0.7
0.7
0.04
186
1759
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
75
1.07
0.07
1.3
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
8
78
1.03
0.07
1.0
1.2
u/l
4.7
6.2
—
8
66
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
273
2765
0.98
0.07
1.7
1.7
pmol/l
33027964.8
28972389.2
0.04
218
2247
(3044941) Cell count panel - Synovial fluid
20
214
0.93
0.07
1.7
1.4
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
24
226
1.06
0.06
1.1
1.4
mmol/l
65.6
64.0
0.06
17
176
(3019309) Folate [Moles/volume] in Red Blood Cells
248
2511
0.99
0.06
1.9
1.8
nmol/l
1126.8
1159.9
0.20
171
1874
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
52
537
0.97
0.06
1.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
24
227
1.06
0.06
1.3
1.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
31
324
0.96
0.05
2.1
1.8
nmol/l
37.1
40.5
0.45
31
309
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
50
486
1.03
0.04
1.4
2.0
u/l
38.1
38.5
0.05
44
422
(3022621) pH of Urine by Test strip
78
796
0.98
0.04
3.2
3.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
125
1234
1.01
0.03
2.3
2.5
ug/l
7.1
7.4
0.09
111
1076
(3003888) Timothy IgE Ab [Units/volume] in Serum
16
151
1.06
0.03
1.1
1.0
u/ml
4.9
5.7
—
7
79
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
15
159
0.94
0.03
1.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
53
540
0.98
0.02
1.2
1.3
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
12
116
1.03
0.00
1.2
1.2
nmol/l
360.9
383.1
0.12
12
101
(3027008) Opiates [Presence] in Urine
29
294
0.99
0.00
1.2
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
112
0.98
0.00
1.0
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
14
138
1.01
0.00
1.0
1.3
—
58.5
—
0
8
(3000764) Benzodiazepines [Presence] in Urine
29
292
0.99
0.00
1.2
1.5
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
25
249
1.00
0.00
1.4
1.3
—
490.0
—
0
6
(4094501)
35
351
1.00
0.00
1.1
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
66
661
1.00
0.00
2.4
2.4
—
—
—
0
0
(4010399)
89
891
1.00
0.00
1.3
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
26
265
0.98
0.00
1.5
1.2
miu/ml
197.7
198.1
—
10
119
(3016879) Cocaine [Presence] in Urine
27
275
0.98
0.00
1.3
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
29
295
0.98
0.00
1.2
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
13
135
0.96
0.00
1.3
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
19
195
0.97
0.00
1.3
2.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
11
105
1.05
0.00
1.5
2.0
u/field
1.3
2.5
—
6
42
(3041672) Baker's yeast Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
70
1.00
0.00
2.3
3.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
7
70
1.00
0.00
4.3
1.2
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.2
—
7.5
—
0
5
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
13
130
1.00
0.00
2.0
2.1
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
0.1
—
0
5
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(4038314)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
53
0.94
0.00
1.0
1.2
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
242.8
—
0
5
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
35
350
1.00
0.00
1.5
1.6
iu/ml
1.0
0.1
—
10
71
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
8
88
0.91
0.00
1.1
1.4
—
73.7
—
0
10
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
54
0.93
0.00
1.0
1.2
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
2.7
—
0
5
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
2.2
—
0
6
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
5
53
0.94
0.00
1.0
1.2
u/ml
—
16.3
—
0
8
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
10.8
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
72
0.97
0.00
2.0
2.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
59
1.02
0.00
1.0
1.1
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_CONNECTIVE_SOFT_NAS_EXALLC – Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).